Literature DB >> 22865552

STAT6 regulates natural helper cell proliferation during lung inflammation initiated by Alternaria.

Taylor A Doherty1, Naseem Khorram, Jinny E Chang, Hee-Kyoo Kim, Peter Rosenthal, Michael Croft, David H Broide.   

Abstract

Asthma exacerbations can be caused by a number of factors, including the fungal allergen Alternaria, which is specifically associated with severe and near-fatal attacks. The mechanisms that trigger lung responses are unclear and might vary between allergens. A comparison between Alternaria, Aspergillus, Candida, and house dust mite, all allergens in humans, showed that only Alternaria promoted immediate innate airway eosinophilia within 12 h of inhalation in nonsensitized mice. Alternaria, but not the other allergens, induced a rapid increase in airway levels of IL-33, accompanied by IL-33 receptor (IL-33R)-positive natural helper cell (NHC) production of IL-5 and IL-13. NHCs in the lung and bone marrow constitutively expressed transcription factors [GATA-3 and E26 transformation-specific sequence-1 (ETS-1)] that could allow for rapid induction of T helper type 2 (Th2) cytokines. Lung NHC numbers and proliferation (%Ki-67), but not IL-5 or GATA-3 expression, were significantly reduced in STAT6-deficient mice 3 days after one challenge with Alternaria. Alternaria induced NHC expression of the EGF receptor ligand amphiregulin (partially dependent on STAT6), as well as EGF receptor signaling in the airway epithelium. Finally, human peripheral blood NHCs (CRTH2(+)CD127(+) lineage-negative lymphocytes) from allergic individuals highly expressed GATA-3 and ETS-1, similar to lung NHCs in mice. In summary, Alternaria-induced lung NHC proliferation and expression of amphiregulin are regulated by STAT6. In addition, NHCs in mouse and humans are primed to express Th2 cytokines through constitutive expression of GATA-3 and ETS-1. Thus several transcription factor pathways (STAT6, GATA-3, and ETS-1) may contribute to NHC proliferation and Th2-type responses in Alternaria-induced asthma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865552      PMCID: PMC3469584          DOI: 10.1152/ajplung.00174.2012

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  46 in total

1.  Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment.

Authors:  W Ouyang; M Löhning; Z Gao; M Assenmacher; S Ranganath; A Radbruch; K M Murphy
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

2.  IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors:  J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

3.  Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-alpha chain and STAT-6 independently of IL-5 and eotaxin.

Authors:  M Yang; S P Hogan; P J Henry; K I Matthaei; A N McKenzie; I G Young; M E Rothenberg; P S Foster
Journal:  Am J Respir Cell Mol Biol       Date:  2001-10       Impact factor: 6.914

Review 4.  IL-13 receptors and signaling pathways: an evolving web.

Authors:  Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2003-04       Impact factor: 10.793

5.  Clinical importance of Alternaria exposure in children.

Authors:  S H Downs; T Z Mitakakis; G B Marks; N G Car; E G Belousova; J D Leüppi; W Xuan; S R Downie; A Tobias; J K Peat
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

6.  The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors.

Authors:  D R Moritz; H R Rodewald; J Gheyselinck; R Klemenz
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

7.  [Clinical characteristics of the fatal and near-fatal asthma in Alternaria alternata sensitized patients].

Authors:  Vicente Plaza; José Serrano; César Picado; Javier Cosano; Julio Ancochea; Alfredo de Diego; Juan José Martín; Joaquín Sanchís
Journal:  Med Clin (Barc)       Date:  2003-11-29       Impact factor: 1.725

8.  Alternaria-induced asthma.

Authors:  Robert K Bush; Jay J Prochnau
Journal:  J Allergy Clin Immunol       Date:  2004-02       Impact factor: 10.793

9.  Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma.

Authors:  M T O'Hollaren; J W Yunginger; K P Offord; M J Somers; E J O'Connell; D J Ballard; M I Sachs
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

10.  IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs.

Authors:  Kathleen R Bartemes; Koji Iijima; Takao Kobayashi; Gail M Kephart; Andrew N McKenzie; Hirohito Kita
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

View more
  79 in total

1.  Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.

Authors:  Elizabeth A Oczypok; Pavle S Milutinovic; John F Alcorn; Anupriya Khare; Lauren T Crum; Michelle L Manni; Michael W Epperly; Adriane M Pawluk; Anuradha Ray; Tim D Oury
Journal:  J Allergy Clin Immunol       Date:  2015-04-28       Impact factor: 10.793

2.  Unconventional ST2- and CD127-negative lung ILC2 populations are induced by the fungal allergen Alternaria alternata.

Authors:  Kellen J Cavagnero; Jana H Badrani; Luay H Naji; Michael B Amadeo; Veranca S Shah; Suzanna Gasparian; Alexa Pham; Alice W Wang; Grégory Seumois; Michael Croft; David H Broide; Taylor A Doherty
Journal:  J Allergy Clin Immunol       Date:  2019-07-29       Impact factor: 10.793

Review 3.  Group 2 innate lymphoid cells in health and disease.

Authors:  Brian S Kim; David Artis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-08       Impact factor: 10.005

Review 4.  Innate lymphoid cells: major players in inflammatory diseases.

Authors:  Mikaël Ebbo; Adeline Crinier; Frédéric Vély; Eric Vivier
Journal:  Nat Rev Immunol       Date:  2017-08-14       Impact factor: 53.106

5.  Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.

Authors:  Sean J Lund; Alex Portillo; Kellen Cavagnero; Rachel E Baum; Luay H Naji; Jana H Badrani; Amit Mehta; Michael Croft; David H Broide; Taylor A Doherty
Journal:  J Immunol       Date:  2017-06-30       Impact factor: 5.422

6.  The Innate Immune Protein S100A9 Protects from T-Helper Cell Type 2-mediated Allergic Airway Inflammation.

Authors:  Lauren D Palmer; K Nichole Maloney; Kelli L Boyd; A Kasia Goleniewska; Shinji Toki; C Noel Maxwell; Walter J Chazin; R Stokes Peebles; Dawn C Newcomb; Eric P Skaar
Journal:  Am J Respir Cell Mol Biol       Date:  2019-10       Impact factor: 6.914

7.  Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84.

Authors:  Taylor A Doherty; David Scott; Hannah H Walford; Naseem Khorram; Sean Lund; Rachel Baum; Jinny Chang; Peter Rosenthal; Andrew Beppu; Marina Miller; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2014-02-28       Impact factor: 10.793

8.  Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis.

Authors:  Jinny E Chang; Taylor A Doherty; Rachel Baum; David Broide
Journal:  J Allergy Clin Immunol       Date:  2013-11-05       Impact factor: 10.793

9.  Innate type 2 response to Alternaria extract enhances ryegrass-induced lung inflammation.

Authors:  Hee-Kyoo Kim; Sean Lund; Rachel Baum; Peter Rosenthal; Naseem Khorram; Taylor A Doherty
Journal:  Int Arch Allergy Immunol       Date:  2013-11-30       Impact factor: 2.749

10.  Pyruvate kinase M2 in lung APCs regulates Alternaria-induced airway inflammation.

Authors:  Anil Kumar Jaiswal; Sangeet Makhija; Natalie Stahr; Maninder Sandey; Amol Suryawanshi; Amarjit Mishra
Journal:  Immunobiology       Date:  2020-05-30       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.